Fig. 1.
Profile of Randomised Controlled Trial. 72 subjects were assessed for eligibility which resulted in 21 subjects evaluated in the placebo group and 18 subjects evaluated in the ALRV5XR (treatment) group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.